Business Description
Genomed SA
NAICS : 325412
SIC : 2834
ISIN : PLGNOMD00024
Description
Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.89 | |||||
| Interest Coverage | 6.59 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 20.95 | |||||
| Beneish M-Score | -2.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.2 | |||||
| 3-Year EBITDA Growth Rate | 14.4 | |||||
| 3-Year EPS without NRI Growth Rate | 31 | |||||
| 3-Year FCF Growth Rate | 25.9 | |||||
| 3-Year Book Growth Rate | 10 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.63 | |||||
| 9-Day RSI | 84.07 | |||||
| 14-Day RSI | 75.02 | |||||
| 6-1 Month Momentum % | -9.29 | |||||
| 12-1 Month Momentum % | -16.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.79 | |||||
| Quick Ratio | 5.72 | |||||
| Cash Ratio | 3.58 | |||||
| Days Inventory | 87.64 | |||||
| Days Sales Outstanding | 25.62 | |||||
| Days Payable | 40.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.97 | |||||
| Operating Margin % | 5.11 | |||||
| Net Margin % | 3.81 | |||||
| FCF Margin % | 0.31 | |||||
| ROE % | 9.31 | |||||
| ROA % | 8.13 | |||||
| ROIC % | 14.79 | |||||
| 3-Year ROIIC % | 63.24 | |||||
| ROC (Joel Greenblatt) % | 22.63 | |||||
| ROCE % | 10.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.33 | |||||
| PE Ratio without NRI | 41.33 | |||||
| Shiller PE Ratio | 35.71 | |||||
| Price-to-Owner-Earnings | 33.29 | |||||
| PS Ratio | 1.57 | |||||
| PB Ratio | 3.76 | |||||
| Price-to-Tangible-Book | 3.8 | |||||
| Price-to-Free-Cash-Flow | 507.41 | |||||
| Price-to-Operating-Cash-Flow | 19.87 | |||||
| EV-to-EBIT | 32.58 | |||||
| EV-to-EBITDA | 19.41 | |||||
| EV-to-Revenue | 1.42 | |||||
| EV-to-FCF | 454.36 | |||||
| Price-to-Projected-FCF | 3.68 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Graham-Number | 2.64 | |||||
| Price-to-Net-Current-Asset-Value | 6.21 | |||||
| Price-to-Net-Cash | 17.91 | |||||
| Earnings Yield (Greenblatt) % | 3.07 | |||||
| FCF Yield % | 0.2 | |||||
| Forward Rate of Return (Yacktman) % | -5.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomed SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 23.065 | ||
| EPS (TTM) (zł) | 0.663 | ||
| Beta | -0.41 | ||
| Volatility % | 13.72 | ||
| 14-Day RSI | 75.02 | ||
| 14-Day ATR (zł) | 0.179501 | ||
| 20-Day SMA (zł) | 26.28 | ||
| 12-1 Month Momentum % | -16.99 | ||
| 52-Week Range (zł) | 25 - 33.4 | ||
| Shares Outstanding (Mil) | 1.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomed SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomed SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomed SA Frequently Asked Questions
What is Genomed SA(WAR:GEN)'s stock price today?
The current price of WAR:GEN is zł27.40. The 52 week high of WAR:GEN is zł33.40 and 52 week low is zł25.00.
When is next earnings date of Genomed SA(WAR:GEN)?
The next earnings date of Genomed SA(WAR:GEN) is .
Does Genomed SA(WAR:GEN) pay dividends? If so, how much?
Genomed SA(WAR:GEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers